Jump to content

Search the Community

Showing results for tags 'Rubella'.

More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Discussions
    • Polio
    • Flu awareness
    • European Immunization Week, 23–29 April 2018
    • Migration and immunization
    • World Hepatitis Day, 28 July 2017
    • European Immunization Week, 24 - 30 April 2017
    • General discussions
    • Education on Immunization
    • Data visualization
    • About NITAGs
    • Research papers, articles, and reports
    • News and social media
    • Updates from partners and stakeholders
    • European Immunization Week (2016)
    • Job opportunities
    • Q&A about the site
    • Innsbruck Treffen (private forum)


  • European Immunization Week 2018
    • Planning resources - EIW 2018
    • Brochures - EIW 2018
    • Infographics - EIW 2018
    • Posters - EIW 2018
    • Banners and social media - EIW 2018
    • Meeting folders - EIW 2018
  • Flu Awareness - 2017
    • Flu Awareness Campaign Posters
  • European Immunization Week 2017
    • Planning resources - EIW 2017
    • Brochures - EIW 2017
    • Infographics - EIW 2017
    • Posters - EIW 2017
    • Banners and social media - EIW 2017
    • Meeting folders - EIW 2017
  • Flu Awareness - 2016
    • Flu Awareness Campaign Posters
  • EIW 2016
    • Planning resources
    • Posters
    • Meeting folders

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...


  • Start



About Me





Found 27 results

  1. Version 1.0.0


    Azerbaijani: EIW 2018 materials
  2. Version 1.0.0


    EIW 2018
  3. Measles cases increase significantly in the last month in a number of EU/EEA countries Measles cases continue to increase in a number of EU/EEA countries. The highest number of cases to date in 2018 were in Romania (1 709), Greece (1 463) France (1 346) and Italy (411) respectively. Thirteen deaths have also been reported by these countries in 2018. Although cases in Romania and Greece remain high, of particular concern is the situation in France and Italy, with cases almost tripling in France since the previous update in March, and more than doubling in Italy. This is according to the most recent measles data collected by ECDC through epidemic intelligence and published in the Communicable Diseases Threats Report (CDTR) today. In the 12-month period between 1 March 2017 and 28 February 2018, 14 813 cases of measles were reported to ECDC through the European Surveillance System which is detailed in ECDC’s monthly measles and rubella monitoring report also published today. Of these cases where age was known, 35% were in children under five and 47% were in those 15 and older. Where vaccination status was known, 86% were unvaccinated. In order to reach elimination and protect those most vulnerable to severe complications and death from measles such as infants, 95% of the population needs to be vaccinated with two doses of measles-containing vaccine. Vaccination coverage was below 95% in 22 out of 29 EU/EEA countries for the second dose of a measles-containing vaccine according to the most recent data collected (WHO 2016), showing that further sustained action is needed. The data further showed the high proportion of cases among young adults who may have missed vaccination, highlighting the need for them to check their vaccination status and get vaccinated if needed. Read more The following outputs are available for a complete overview of data regarding measles outbreaks in the EU/EEA Communicable Disease Threat Report - “Measles and Rubella, Monitoring European and worldwide outbreaks” - Epidemic intelligence data Monthly measles and rubella monitoring report - European Surveillance System data (TESSy) Rapid risk assessment: risk of measles transmission in the EU/EEA – TESSy and epidemic intelligence data Bi-annual measles and rubella monitoring report -TESSy and epidemic intelligence data ECDC Atlas of Infectious Diseases -TESSy data ECDC vaccine scheduler
  4. Version 1.0.0


    Rubella infographic in PDF (green download button on the right) or in editable AI format (Adobe Illustrator) here: Rubella_EIW_2018_WHO_FINAL.ai
  5. WHO/Europe is looking for qualified experts interested in playing a key role in measles and rubella elimination as (volunteer) members of the RVC. The application deadline is 30 September 2017. http://www.euro.who.int/en/about-us/jobs-and-internships/short-term-opportunities/call-for-expressions-of-interest-in-serving-as-member-of-the-european-regional-verification-commission-for-measles-and-rubella-elimination-rvc
  6. Ukraine is among only 14 countries in the WHO European Region where measles and rubella remain endemic. With WHO support, a national conference on measles and rubella elimination held on 21–22 February 2017 in Kyiv.
  7. until
    ECDC's Lucia Pastore Celentano, Head of the Vaccine Preventable Disease program will present on "Recent epidemiology and outbreaks of measles in Europe" at the ECCMID conference in Vienna. LuciaPC_ECCMID_240417_measles_final.pptx
  8. Measles does not only affect children: trends for 2016 and outbreaks in Europe during 2017 During the first 2 months of 2017 we have seen 1524 cases of measles reported from 14 EU/EEA countries. Measles does not only affect children but also older age groups. In 2014 over half of the cases were in adults over 20 years old, in 2015 and 2016 this age group accounted for approximately one third of all cases. Closing immunisation gaps in adolescents and adults who have not received vaccination in the past as well as strengthening routine childhood immunisation programmes will be vital to prevent future outbreaks and reach the elimination goal. The only way to prevent illness, disability and death from vaccine preventable diseases is through timely and complete vaccination according to each country’s national immunization schedule. ECDC joins the European Immunization Week initiative to increase awareness of the importance of immunisation throughout life and thereby help build and sustain immunity in all communities throughout the European Region. ECDC Acting Director Dr Andrea Ammon said “It is worrying to see accumulation of unvaccinated individuals and as a consequence outbreaks of measles in several European countries in recent months.” Ammon continues “A further challenge in reaching the elimination goal in Europe is the high proportion of cases observed in older age groups. In 2016 28% of measles cases were above 20 years old. ” Many adults do not realize that they are susceptible to vaccine preventable diseases. They may not have had access to currently available vaccines as a child, nor developed immunity to the diseases through natural infection. The age group accounting for the largest proportion of measles cases in both 2014 and 2015 was the over 20 year olds (53% in 2014, 38% in 2015). This highlights the importance of closing immunisation gaps in adolescents and adults who have not received vaccination in the past. "It is inacceptable to hear that children and adults are dying from disease where safe and cost-effective vaccines are available. Though vaccine coverage remains relatively high in the EU, we need to continue our efforts to raise awareness and acceptance of vaccination", says Vytenis Andriukaitis, European Commissioner for Health and Food Safety. "The Commission is committed to stepping up EU support for national immunisation strategies. Improving access to vaccines, addressing vaccine shortages, countering vaccine hesitancy, facilitating comprehensive vaccination programmes and strengthening research and development are among our priorities." In the last twelve months, between 1 March 2016 and 28 February 2017, 5 881 cases of measles were reported by 30 EU/EEA countries; Romania accounted for 46% of all cases reported in this period. Other countries with a high proportion of cases were Italy (24 %), the United Kingdom (9%). A measles outbreak is ongoing in Romania and cases continue to be reported despite response measures that have been implemented at national level through reinforced vaccination activities. Since 1 January 2016 and as of 7 April 2017 a total of 4 090 cases were reported. In 2016, a number of other EU/EEA countries reported measles outbreaks, and an increase in the number of cases continues to be observed in 2017. In 10 countries (Austria, Belgium, Croatia, France, Germany, Italy, Poland, Romania, Spain and Sweden) the number of cases reported in January-February 2017 was more than double compared to the same period in 2016. Despite the progress towards measles elimination reported by The Regional Verification Commission for Measles and Rubella Elimination the vaccination coverage is still sub-optimal in many EU/EEA countries. Interrupting transmission requires at least 95% vaccination coverage with two doses in every district and community. The latest available data (2015) shows that the vaccination coverage for the second dose of measles was below 95% in 15 of 23 EU/EEA countries reporting on the second dose. The vaccination coverage for the first dose of measles was below 95% in 12 of 27 EU/EEA countries reporting on the first dose. If the elimination goal is to be reached, the vaccination coverage rates for children targeted by routine vaccination programmes will have to be increased in a number of countries. Also, immunisation gaps need to be closed in adolescents and adults who have missed opportunities for vaccination in the past. b. Graphics Trends for ECDC measles and rubella monitoring, 2013-2016.pptx Biannual measles rubella monitoring.pdf Measles_infographic.pdf
  9. The RVC met for the fifth time on 24–26 October 2016 in Copenhagen, Denmark. The 8-member panel evaluated annual status updates for 2015 and other documentation submitted by national verification committees, now established in 51 out of 53 Member States. The RVC concluded that as of the end of 2015, endemic measles transmission was interrupted in 37 Member States, and endemic rubella transmission was interrupted in 35 Member States. Link to the page on WHO website Direct link to the report RVC page
  10. The European Regional Verification Commission for Measles and Rubella Elimination (RVC) concluded last month that 37 countries out of 53 in the European Region have demonstrated interruption of endemic transmission of measles. 35 of these countries have also demonstrated interruption of rubella. http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/news/news/2016/11/europe-making-steady-progress-toward-measles-and-rubella-elimination More good news is the lower total numbers of cases so far in 2016 compared to previous years. Jan-Sept 2016: http://www.euro.who.int/__data/assets/pdf_file/0017/324206/EpiData-No03-2016.pdf?ua=1 Jan-Dec 2015: http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publications/who-epibrief-and-who-epidata/who-epidata/who-epidata,-jan.dec.-2015 Unfortunately, these tables also demonstrate that endemic circulation, or transmission after importation, will continue to be a threat wherever there are pockets of under-immunization.
  11. until
    Fifth Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC) 24-26 October 2016, Copenhagen, Denmark The European Regional Verification Commission for Measles and Rubella Elimination (RVC) holds annual meetings to determine the status of measles and rubella elimination in the WHO European Region based on reports and additional documents prepared and submitted by national verification committees (NVCs). Based on this review, the RVC will declare the status of the transmission and eventual achievement of elimination of measles and rubella in Member States and in the WHO European Region. The main objectives of the 2016 annual meeting will be: to inform the RVC about current epidemiology of measles and rubella in the European Region and activities of the Regional Office and the Vaccine-preventable Diseases and Immunization programme towards measles and rubella elimination, as well as global developments on measles and rubella control and elimination; to review the NVCs’ annual measles and rubella status updates for 2015, late-submitted reports for previous years and all other documentation that NVCs provide towards documenting the absence of measles and rubella endemic transmission in their countries; to define the status of transmission of measles and rubella in each Member State and in the Region in 2015; to declare the diseases’ elimination where achieved and declare the status of measles and rubella in the European Region considering the 2015 elimination targets.
  12. The countries of Europe are working together to tackle the threat of measles and rubella, but Region-wide elimination has been elusive. The London School of Hygiene and Tropical Medicine (LSHTM) in collaboration with WHO/Europe will host a 1-day public event on 20 September focused on what has worked in reducing the prevalence of measles and rubella and what more can be done to eliminate them. This event will draw together experts in disease control, health policy and implementation, epidemiology, behavioural science, and the media to share experiences and discuss the way forward. The event is open to the public (online registration required) and can be followed live online. Programme 10.15 – 10.45 Tea/Coffee 10.45 – 11.15 “Measles & Rubella: A Global and Regional Picture” Speaker: Jean-Marie Okwo-Bele (WHO) 11:15 – 12:30 Country Experiences: Lessons Learnt and Best Practices Chair: Anthony Scott (LSHTM) “Communicating and Motivating to Reach the Goal: Insights of an Immunization Programme Manager” Speaker: Gayane Sahakyan (NIP Manager) “Measles and Rubella Elimination in the Netherlands: Lessons learnt and challenges for the future” Speaker: Susan Hahné (National Institute for Public Health and the Environment, RIVM) "PAHO's Experience of Eliminating Rubella” Speaker: Susan Reef (US Centers for Diseases Control and Prevention) 12:30 - 13:30 Lunch 13.30 - 15.00 Recent Advances in Controlling Measles and Rubella Chair John Edmunds (LSHTM) “Target Immunity Levels for Achieving Measles Elimination” - Speaker: Sebastian Funk (LSHTM) “Convulsions, Autism, Meningitis, Gait Disturbance: Sorting the Wheat from the Chaff in Vaccine Safety Assessment" Speaker: Nick Andrews (PHE) “Understanding Vaccine Hesitancy” Speaker: Pauline Paterson (LSHTM) 15:00 – 15:30 Tea/Coffee 15.30 – 17.00 Panel discussion: Challenges with Elimination and How They Can Be Overcome Chair: Robb Butler (WHO) Elizabeth Miller OBE (Public Health England) Günter Pfaff (Regional Verification Commission for Measles and Rubella Elimination) Andy Pollard (Oxford, SAGE) Fiona Fox (Science Media Centre, UK) Jean-Marie Okwo-Bele (WHO) Live streaming: 10:30-12:30 Jean-Marie Okwo-Bele & Country Experiences: Lessons Learnt and Best Practices https://panopto.lshtm.ac.uk/Panopto/Pages/Viewer.aspx?id=b7273000-94ad-47da-badc-ebf1bf02eeba 13:30-15:00 Recent Advances in Controlling Measles and Rubella https://panopto.lshtm.ac.uk/Panopto/Pages/Viewer.aspx?id=2f02943b-3957-444a-be6d-307ac293d5b2 15:30-17:00 Panel discussion: Challenges with Elimination and How They Can Be Overcome https://panopto.lshtm.ac.uk/Panopto/Pages/Viewer.aspx?id=26a8f8d3-c174-4b73-9050-d791caeb2637
  13. Health care workers and all professionals working in the field of immunization have a crucial role to play in allaying vaccine safety fears, tackling vaccine hesitancy and emphasising the benefits and the value of vaccines. Communities need to be supported in seeing the value of vaccines not just for individuals, but for society, and as part of being a responsible citizen. Healthcare workers also have a responsibility to protect patients‘ health by being vaccinated themselves and reducing transmission. For decades, Dr Louis Cooper has demonstrated the huge impact that health care workers can have on promoting vaccine uptake and ensuring equitable delivery. In his post on the Immunize Europe Forum today (http://www.immunize-europe.org/topic/135-education-that-encourages-dialogue), the former President of the American Academy of Paediatrics, talks about communication with parents and children. Dr. Cooper was initially a clinician-researcher in infectious diseases in New York City in the early 1970s. After seeing the large burden of vaccine-preventable diseases and their serious consequences, he has dedicated much of his life to changing U.S. public health policy about vaccinations including helping to create a federal entitlement to the recommended vaccinations such as measles and rubella.
  14. Germany is one of the countries in the European Region where measles and rubella continue to spread, according to the recent assessment of the European Regional Verification Commission for measles and rubella elimination (RVC). Last year Germany adopted a national plan of action for elimination of these diseases that identifies the remaining gaps and barriers and sets detailed targets to overcome them. The Ministry of Health has now added an English summary of the plan (p.8-9) to the full document: https://www.bundesgesundheitsministerium.de/fileadmin/dateien/Publikationen/Gesundheit/Broschueren/Aktionsplan_Masern_Roeteln.pdf The “National Action Plan for the Elimination of Measles and Rubella in Germany 2015––2020” was initiated in 2014 by a working group consisting of representatives from federal health authorities, the federal states, and other relevant stakeholders (e.g. professional societies and health insurance companies). The Action Plan was discussed at a national conference on the elimination of measles and rubella with relevant stakeholders in December 2014 and endorsed in June 2015 by the health ministers of the federal states in Germany. BMG_Masern_Roeteln_2016_03_abstract english.pdf
  15. ECDC 2016 http://ecdc.europa.eu/en/healthtopics/immunisation/Documents/ECDC-rubella-infographic_2016.pdf
  16. Azerbaijan is among the 21 Member States of the WHO European Region that eliminated endemic transmission of measles, and one of the 20 that eliminated endemic transmission of rubella as of 2014. Azerbaijan utilized European Immunization Week not only to highlight its measles and rubella elimination status, but also to proactively address the Regional Verification Commission’s recommendations for the country to maintain elimination. Read more: http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/news/news/2016/04/european-immunization-week-in-azerbaijan-dedicated-to-maintaining-progress-in-disease-prevention
  17. In this interview with Vaccines Today, Robb Butler, Programme Manager of the Vaccine-preventable Diseases and Immunization programme of the WHO Regional Office for Europe, explains why things are looking up for measles and rubella elimination in the Region and what needs to be done to finish the job: http://www.vaccinestoday.eu/vaccines/measles-and-rubella-elimination-gaining-momentum/?platform=hootsuite
  18. Thirty-two countries in the European Region have interrupted transmission of endemic measles and/or rubella as of 2014, according to the conclusions of the European Regional Verification Commission for Measles and Rubella Elimination (RVC). Azerbaijan is among those countries that have sustained interruption for a period of three years and are therefore considered to have eliminated measles and rubella. This progress and momentum toward elimination in the entire European Region will be the focus of European Immunization Week, taking place 24-30 April. Interruption of transmission in more than half of Europe’s countries shows that regional elimination of measles and rubella is possible and we are on the right track to achieve it. Momentum must be maintained to sustain this achievement where it is still fragile, and to ensure the remaining endemic countries catch up quickly. Read the full update on the UN in Azerbaijan website.
  19. During the course of European Immunisation Week (EIW), 24 – 30 April 2016, ECDC is putting the spotlight on its resources in support of measles and rubella elimination. These range from disease surveillance and epidemic intelligence to communication tools and guides on awareness raising about the importance of vaccination, as well as the vaccination scheduler tool. Read more and access resources on ECDC's website
  20. Despite being vaccine-preventable, once-common childhood diseases are still endemic across the EU, reports Colin Mackay. Sunday 24 April sees the start of European Immunisation Week (EIW). The goal of EIW is to increase vaccination coverage by raising awareness of the importance of immunisation. This year, EIW will focus on addressing the challenges that Europe faces in its efforts to eliminate measles and rubella. At first glance, this may appear to be tackling diseases of the past, but, both of these highly infectious conditions have been on the rise once again in recent years. Read the full article on TheParliamentMagazine.eu.
  21. Over half of the 53 countries in the WHO European Region have interrupted endemic transmission of measles and rubella.
  22. Over half of the 53 countries in the WHO European Region have interrupted endemic transmission of measles and rubella.
  23. EIW focuses this year on progress towards measles and rubella elimination. Today's press release announces that over half of countries in the European Region have interrupted endemic transmission, based on 2014 reports to the European Regional Verification Commission for Measles and Rubella Elimination (RVC). See the RVC's conclusions and recommendations for further progress in its 4th meeting report.
  • Create New...